Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep 21;9(9):CD010022.
doi: 10.1002/14651858.CD010022.pub2.

Alcohol intake reduction for controlling hypertension

Maria Teresa Acin  1 , José-Ramón Rueda  2 , Luis Carlos Saiz  3 , Veronica Parent Mathias  4 , Natalia Alzueta  1 , Ivan Solà  5 , Javier Garjón  6 , Juan Erviti  3
Affiliations

Alcohol intake reduction for controlling hypertension

Maria Teresa Acin et al. Cochrane Database Syst Rev. .

Abstract

Background: High blood pressure constitutes one of the leading causes of mortality and morbidity all over the world. At the same time, heavy drinking increases the risk for developing cardiovascular diseases, including cardiomyopathy, hypertension, atrial arrhythmias, or stroke. Several studies have already assessed specifically the relationship between alcohol intake and hypertension. However, the potential effect on blood pressure of alcohol intake reduction interventions is largely unknown.

Objectives: To assess the effect of any intervention to reduce alcohol intake in terms of blood pressure decrease in hypertensive people with alcohol consumption compared to a control intervention or no intervention at all. To determine additional effects related to mortality, major cardiovascular events, serious adverse events, or quality of life.

Search methods: The Cochrane Hypertension Information Specialist searched the following databases for randomised controlled trials up to June 2020: the Cochrane Hypertension Specialised Register, the Cochrane Central Register of Controlled Trials (CENTRAL) (Issue 5, 2020), MEDLINE Ovid (from 1946), MEDLINE Ovid Epub Ahead of Print, and MEDLINE Ovid In-Process, Embase Ovid (from 1974), ClinicalTrials.gov and the World Health Organization International Clinical Trials Registry Platform. Trial authors were contacted when needed and no language restrictions were applied.

Selection criteria: We included randomised controlled trials with minimum 12 weeks duration and including 50 or more subjects per group with quantitative measurement of alcohol consumption and/or biological measurement of the outcomes of interest. Participants were adults (16 years of age or older) with systolic blood pressure (SBP) greater than 140 mmHg and diastolic blood pressure (DBP) greater than 90 mmHg, and SBP ≥ 130 or DBP ≥ 80 mmHg in participants with diabetes. We included any intervention implemented to reduce their alcohol intake.

Data collection and analysis: Two review authors independently assessed search results and extracted data using standard methodological procedures adopted by Cochrane.

Main results: A total of 1210 studies were screened. We included one randomised controlled trial involving a total of 269 participants with a two-year follow-up. Individual patient data for all participants were provided and used in this review. No differences were found between the cognitive-behavioural intervention group and the control group for overall mortality (RR 0.72, 95% CI 0.16 to 3.17; low-certainty evidence), cardiovascular mortality (not estimable) and cardiovascular events (RR 0.80, 95% CI 0.36 to 1.79; very low-certainty evidence). There was no statistical difference in systolic blood pressure (SBP) reduction (Mean Difference (MD) -0.92 mmHg, 95% confidence interval (CI) -5.66 to 3.82 mmHg; very low-certainty evidence) or diastolic blood pressure (DBP) decrease (MD 0.98 mmHg, 95% CI -1.69 to 3.65 mmHg; low-certainty evidence) between the cognitive-behavioural intervention group and the control group. We also did not find any differences in the proportion of subjects with SBP < 140 mmHg and DBP < 90 mmHg (Risk Ratio (RR) 1.21, 95% CI 0.88 to 1.65; very low-certainty evidence). Concerning secondary outcomes, the alcohol intake was significantly reduced in the cognitive-behavioural intervention compared with the control group (MD 191.33 g, 95% CI 85.36 to 297.30 g). We found no differences between the active and control intervention in the proportion of subjects with lower-risk alcohol intake versus higher-risk and extreme drinkers at the end of the study (RR 1.04, 95% CI 0.68 to 1.60). There were no estimable results for the quality of life outcome.

Authors' conclusions: An intervention for decreasing alcohol intake consumption did not result in differences in systolic and diastolic blood pressure when compared with a control intervention, although there was a reduction in alcohol intake favouring the active intervention. No differences were found either for overall mortality, cardiovascular mortality or cardiovascular events. No data on serious adverse events or quality of life were available to assess. Adequate randomised controlled trials are needed to provide additional evidence on this specific question.

Trial registration: ClinicalTrials.gov NCT00006206.

PubMed Disclaimer

Conflict of interest statement

MT Acín: none known.

N Alzueta: none known.

V Parent Mathias:none known.

JR Rueda: none known.

I Solá: none known.

J Garjón: none known.

LC Saiz: none known.

J Erviti: none known.

Figures

1
1
PRISMA flow diagram
2
2
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
1.1
1.1. Analysis
Comparison 1: Intervention on reducing alcohol intake versus control for controlling hypertension, Outcome 1: Decrease in systolic blood pressure
1.2
1.2. Analysis
Comparison 1: Intervention on reducing alcohol intake versus control for controlling hypertension, Outcome 2: Decrease of diastolic blood pressure
1.3
1.3. Analysis
Comparison 1: Intervention on reducing alcohol intake versus control for controlling hypertension, Outcome 3: Proportion of subjects with SBP < 140 mmHg and DBP < 90 mmHg
1.4
1.4. Analysis
Comparison 1: Intervention on reducing alcohol intake versus control for controlling hypertension, Outcome 4: Cardiovascular events
1.5
1.5. Analysis
Comparison 1: Intervention on reducing alcohol intake versus control for controlling hypertension, Outcome 5: Overall mortality
1.6
1.6. Analysis
Comparison 1: Intervention on reducing alcohol intake versus control for controlling hypertension, Outcome 6: Decreased alcohol intake
1.7
1.7. Analysis
Comparison 1: Intervention on reducing alcohol intake versus control for controlling hypertension, Outcome 7: Proportion of subjects with lower‐risk alcohol intake
1.8
1.8. Analysis
Comparison 1: Intervention on reducing alcohol intake versus control for controlling hypertension, Outcome 8: Proportion of subjects with higher‐risk and extreme drinkers
See this image and copyright information in PMC

Update of

References

References to studies included in this review

PATHS 1998 {published and unpublished data}
    1. Cushman WC, Cutler JA, Bingham SF, Harford T, Hanna E, Dubbert P, et al. Prevention and treatment of hypertension study (PATHS). Rationale and design. American Journal of Hypertension 1994;7(9 Pt 1):814-23. [DOI: 10.1093/ajh/7.9.814] - DOI - PubMed
    1. Cushman WC, Cutler JA, Hanna E, Bingham SF, Follmann D, Harford T, et al. Prevention and treatment of hypertension study (PATHS): effects of an alcohol treatment program on blood pressure. Archives of Internal Medicine 1998;158(11):1197-207. [DOI: 10.1001/archinte.158.11.1197] - DOI - PubMed

References to studies excluded from this review

Avram 2009 {published data only}
    1. Avram O, Grecu I, Macovei R, Marinescu O, Grintescu I. Benefits of implementation of a protocol for identification of preoperative chronic alcohol abusers and for alcohol withdrawal syndrome prevention [Beneficiile implementării unui protocol pentru identificarea preoperatorie a pacienţilor cu alcoolism cronic şi profilaxia sindromului de sevraj etilic perioperator]. Jurnalul Român de Anestezie Terapie Intensiva 2009;16(2):121-7.
Baros 2008 {published data only}
    1. Anton RF, Moak DH, Latham P, Waid LR, Myrick H, Voronin K, et al. Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence. Journal of Clinical Psychopharmacology 2005;25(4):349-57. [DOI: 10.1097/01.jcp.0000172071.81258.04] - DOI - PubMed
    1. Baros AM, Wright TM, Latham PK, Miller PM, Anton RF. Alcohol consumption, %CDT, GGT and blood pressure change during alcohol treatment. Alcohol & Alcoholism 2008;43(2):192-7. [DOI: 10.1093/alcalc/agm156] - DOI - PubMed
BHAIT 2015 {published data only}85355606
    1. Grimm C. Bradford hypertension and alcohol intervention trial: a randomised cluster trial. www.isrctn.com/ISRCTN85355606?q=Grimm&filters=&sort=&offset=... (date first received 1 July 2015). [DOI: 10.1186/ISRCTN85355606] - DOI
Bjorkqvist 1975 {published data only}
    1. Bjorkqvist SE. Clonidine in alcohol withdrawal. Acta Psychiatrica Scandinavica 1975;52(4):256-63. - PubMed
Bulpitt 1999 {published data only}
    1. Bulpitt CJ, Shipley MJ. Failure of alcohol reduction to lower blood pressure in the PATHS trial. Prevention and treatment of hypertension study. Archives of Internal Medicine 1999;159(2):195-6. [DOI: 10.1001/archinte.159.2.195] - DOI - PubMed
Burke 2006 {published data only}
    1. Burke V, Beilin LJ, Cutt HE, Mansour J, Williams A, Mori TA. A lifestyle program for treated hypertensives improved health-related behaviors and cardiovascular risk factors, a randomized controlled trial. Journal of Clinical Epidemiology 2007;60:133-41. [DOI: 10.1016/j.jclinepi.2006.05.012] - DOI - PubMed
Chang 2011 {published data only}
    1. Chang G, Fisher NDL, Hornstein MD, Jones JA, Hauke SH, Niamkey N, et al. Brief intervention for women with risky drinking and medical diagnoses: a randomized controlled trial. Journal of Substance Abuse Treatment 2011;41(2):105-14. [DOI: 10.1016/j.jsat.2011.02.011] - DOI - PMC - PubMed
Cicolini 2014 {published data only}
    1. Cicolini G, Simonetti V, Comparcini D, Celiberti I, Di Nicola M, Capasso LM, et al. Efficacy of a nurse-led email reminder program for cardiovascular prevention risk reduction in hypertensive patients: a randomized controlled trial. International Journal of Nursing Studies 2014;51(6):833-43. [DOI: 10.1016/j.ijnurstu.2013.10.010] - DOI - PubMed
COMBINE 2006 {published data only (unpublished sought but not used)}
    1. Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence. The COMBINE study: a randomized controlled trial. JAMA 2006;295(17):2003-17. [DOI: 10.1001/jama.295.17.2003] - DOI - PubMed
    1. Stewart SH, Latham PK, Miller PM, Randall P, Anton RF. Blood pressure reduction during treatment for alcohol dependence: results from the COmbining Medications and Behavioral INtErventions for alcoholism (COMBINE) study. Addiction 2008;103(10):1622-8. [DOI: 10.1111/j.1360-0443.2008.02317.x] - DOI - PMC - PubMed
Coulton 2008 {published data only}
    1. Coulton S, Watson J, Bland M, Drummond C, Kaner E, Godfrey C, et al. The effectiveness and cost-effectiveness of opportunistic screening and stepped care interventions for older hazardous alcohol users in primary care (AESOPS) - a randomised control trial protocol. BMC Health Services Research 2008;8:129. [DOI: 10.1186/1472-6963-8-129] - DOI - PMC - PubMed
De Bejczy 2014 {published data only}
    1. De Bejczy A, Nations KR, Szegedi A, Schoemaker J, Ruwe F, Söderpalm B. Efficacy and safety of the glycine transporter-1 inhibitor Org 25935 for the prevention of relapse in alcohol-dependent patients: a randomized, double-blind, placebo-controlled trial. Alcoholism, Clinical & Experimental Research 2014;38(9):2427-35. [DOI: 10.1111/acer.12501 ] - PubMed
Dennison 2007 {published data only}
    1. Dennison CR, Post WS, Kim MT, Bone LR, Cohen D, Blumenthal RS, et al. Underserved urban African American men: hypertension trial outcomes and mortality during 5 years. American Journal of Hypertension 2007;20(2):164-71. [DOI: 10.1016/j.amjhyper.2006.08.003 ] - PubMed
ETOH‐AF 2016 {published data only}
    1. Voskoboinik A, Kalman JM, De Silva A, Nicholls T, Costello B, Nanayakkara S, et al. Alcohol abstinence in drinkers with atrial fibrillation. NEJM 2020;382:oa1817591. [DOI: 10.1056/NEJMoa1817591] - DOI - PubMed
Fleming 1999 {published data only}
    1. Fleming MF, Manwell LB, Barry KL, Adams W, Stauffacher EA. Brief physician advice for alcohol problems in older adults: a randomized community-based trial. Journal of Family Practice 1999;48(5):378-84. [PMID: ] - PubMed
Fleming 2004 {published data only}
    1. Fleming M, Brown R, Brown D. The efficacy of a brief alcohol intervention combined with %CDT feedback in patients being treated for type 2 diabetes and/or hypertension. Journal of Studies on Alcohol 2004;65(5):631-7. [DOI: 10.15288/jsa.2004.65.631] - DOI - PubMed
Heirich 2000 {published and unpublished data}
    1. Heirich M, Sieck CJ. Worksite cardiovascular wellness programs as a route to substance abuse prevention. Journal of Occupational and Environmental Medicine 2000;42(1):47-56. [DOI: 10.1097/00043764-200001000-00013] - DOI - PubMed
Lang 1995 {published data only}
    1. Lang T, Nicaud V, Darné B, Rueff B. Improving hypertension control among excessive alcohol drinkers: a randomised controlled trial in France. The WALPA Group. Journal of Epidemiology and Community Health 1995;49(6):610-6. [DOI: 10.1136/jech.49.6.610] - DOI - PMC - PubMed
Rose 2008 {published data only}
    1. Rose HL, Miller PM, Nemeth LS, Jenkins RG, Nietert PJ, Wessell AM, et al. Alcohol screening and brief counseling in a primary care hypertensive population: a quality improvement intervention. Addiction 2008;103:1271-80. [DOI: 10.1111/j.1360-0443.2008.02199.x] - DOI - PubMed
Soyka 2008 {published and unpublished data}
    1. Soyka M, Koller G, Schmidt P, Lesch OM, Leweke M, Fehr C, et al. Cannabinoid receptor 1 blocker rimonabant (SR 141716) for treatment of alcohol dependence. Results from a placebo-controlled, double-blind trial. Journal of Clinical Psychopharmacology 2008;28(3):317-24. [DOI: 10.1097/JCP.0b013e318172b8bc] - DOI - PubMed
Ueshima 1989 {published and unpublished data}
    1. Ueshima H. Non-drug treatment of mild hypertension and its limits: hypotensive effect of cutting down on drinking and its limits. Therapeutic Research 1989;10(7):2614-9.
Ueshima 1993 {published data only}
    1. Ueshima H, Mikawa K, Baba S, Sasaki S, Ozawa H, Tsushima M, et al. Effect of reduced alcohol consumption on blood pressure in untreated hypertensive men. Hypertension 1993;21(2):248-52. [10.1161/01.hyp.21.2.248 ] - PubMed
Volicer 1982 {published data only}
    1. Volicer BJ, Volicer L. Randomized response technique for estimating alcohol use and noncompliance in hypertensives. Journal of Studies on Alcohol 1982;43(7):739-50. [DOI: 10.15288/jsa.1982.43.739 ] - PubMed
Wallace 1988 {published data only (unpublished sought but not used)}
    1. Wallace P, Cutler S, Haines A. Randomised controlled trial of general practitioner intervention in patients with excessive alcohol consumption. BMJ 1988;297:663-8. [DOI: 10.1136/bmj.297.6649.663] - DOI - PMC - PubMed
Wilson 2014 {published data only}
    1. Wilson GB, Wray C, McGovern R, Newbury-Birch D, McColl E, Crosland A, et al. Intervention to reduce excessive alcohol consumption and improve comorbidity outcomes in hypertensive or depressed primary care patients: two parallel cluster randomized feasibility trials. Trials 2014;15(235):1-15. [DOI: 10.1186/1745-6215-15-235] - DOI - PMC - PubMed

References to studies awaiting assessment

OSAKE 2015 {unpublished data only}UMIN000017454
    1. A randomized controlled trial of saving alcohol amount program for keeping optimal blood pressure control in patients with hypertension. The University Hospital Medical Information Network Center (UMIN);Osaka University Graduate School of Medicine Division of Health Sciences:Available at: https://rctportal.niph.go.jp/en/detail?trial_id=UMIN000017454. [UMIN ID: UMIN000017454]

Additional references

Amato 2010
    1. Amato L, Minozzi S, Vecchi S, Davoli M. Benzodiazepines for alcohol withdrawal. Cochrane Database of Systematic Reviews 2010, Issue 3. Art. No: CD005063. [DOI: 10.1002/14651858.CD005063.pub3] - DOI - PubMed
Briasoulis 2012
    1. Briasoulis A, Agarwal V, Messerli FH. Alcohol consumption and the risk of hypertension in men and women: a systematic review and meta-analysis. Journal of Clinical Hypertension 2012;14:792-8. [DOI: 10.1111/jch.12008] - DOI - PMC - PubMed
Burton 2016
    1. Burton R, Henn C, Lavoie D, O'Connor R, Perkins C, Sweeney K, et al. A rapid evidence review of the effectiveness and cost-effectiveness of alcohol control policies: an English perspective. Lancet 2016;389(10078):1558-80. [DOI: 10.1016/S0140-6736(16)32420-5] - DOI - PubMed
Cushman 2001
    1. Cushman WC. Alcohol consumption and hypertension. Journal of Clinical Hypertension 2001;3(3):166-70. [DOI: 10.1111/j.1524-6175.2001.00443.x] - DOI - PMC - PubMed
Fernández‐Solà 2015
    1. Fernández-Solà J. Cardiovascular risks and benefits of moderate and heavy alcohol consumption. Nature Reviews Cardiology 2015;12(10):576-87. [DOI: 10.1038/nrcardio.2015.91] - DOI - PubMed
Ferri 2006
    1. Ferri M, Amato L, Davoli M. Alcoholics Anonymous and other 12-step programmes for alcohol dependence. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No: CD005032. [DOI: 10.1002/14651858.CD005032.pub2] - DOI - PMC - PubMed
Foxcroft 2015
    1. Foxcroft DR, Moreira MT, Almeida Santimano NM, Smith LA. Social norms information for alcohol misuse in university and college students. Cochrane Database of Systematic Reviews 2015, Issue 12. Art. No: CD006748. [DOI: 10.1002/14651858.CD006748.pub4] - DOI - PMC - PubMed
Foxcroft 2016
    1. Foxcroft DR, Coombes L, Wood S, Allen D, Almeida Santimano NML, Moreira MT. Motivational interviewing for the prevention of alcohol misuse in young adults. Cochrane Database of Systematic Reviews 2016, Issue 7. Art. No: CD007025. [DOI: 10.1002/14651858.CD007025.pub4] - DOI - PMC - PubMed
GBD 2016
    1. GBD 2016 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017;390(10100):1345-422. [DOI: 10.1016/S0140-6736(17)32366-8] - DOI - PMC - PubMed
Gepner 2015
    1. Gepner Y, Golan R, Harman-Boehm I, Henkin Y, Schwarzfuchs D, Shelef I, et al. Effects of initiating moderate alcohol intake on cardiometabolic risk in adults with type 2 diabetes: a 2-year randomized, controlled trial. Annals of Internal Medicine 2015;163(8):569-79. [DOI: 10.7326/M14-1650 ] - PubMed
Gepner 2016
    1. Gepner Y, Henkin Y, Schwarzfuchs D, Golan R, Durst R, Shelef I, et al. Differential effect of initiating moderate red wine consumption on 24-h blood pressure by alcohol dehydrogenase genotypes: randomized trial in type 2 diabetes. American Journal of Hypertension 2016;29(4):476-83. [DOI: 10.1093/ajh/hpv126] - DOI - PMC - PubMed
Gilligan 2016
    1. Gilligan C, Wolfenden L, Foxcroft DR, Kingsland M, Williams AJ, Hodder RK, et al. Family-based prevention programs for alcohol use in young people. Cochrane Database of Systematic Reviews 2016, Issue 8. Art. No: CD012287. [DOI: 10.1002/14651858.CD012287] - DOI - PMC - PubMed
GRADEpro [Computer program]
    1. McMaster University (developed by Evidence Prime Inc.) GRADEpro GDT: GRADEpro Guideline Development Tool. McMaster University (developed by Evidence Prime Inc.), 2015. Available from gradepro.org.
Higgins 2011
    1. Higgins JPT, Altman DG, Sterne JAC. Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Hypertension Canada 2018
    1. Nerenberg KA, Zarnke KB, Leung AA, Dasgupta K, Butalia S, McBrien K, et al. Hypertension Canada's 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children. Canadian Journal of Cardiology 2018;34(5):506-25. [DOI: 10.1016/j.cjca.2018.02.022] - DOI - PubMed
ICH 1995
    1. European Medicines Agency. Clinical safety data management: definitions and standards for expedited reporting. www.ema.europa.eu/en/ich-e2a-clinical-safety-data-management-definitions... (accessed prior to 16 September 2020).
Ipser 2015
    1. Ipser JC, Wilson D, Akindipe TO, Sager C, Stein DJ. Pharmacotherapy for anxiety and comorbid alcohol use disorders. Cochrane Database of Systematic Reviews 2015, Issue 1. Art. No: CD007505. [DOI: 10.1002/14651858.CD007505.pub2] - DOI - PMC - PubMed
Ismail 2010
    1. Ismail K, Maissi E, Thomas S, Chalder T, Schmidt U, Bartlett J, et al. A randomised controlled trial of cognitive behaviour therapy and motivational interviewing for people with Type 1 diabetes mellitus with persistent sub-optimal glycaemic control: A Diabetes and Psychological Therapies (ADaPT) study. Health Technology Assessment 2010;14(22):1-101, iii-iv. - PubMed
Kaner 2018
    1. Kaner EFS, Beyer FR, Muirhead C, Campbell F, Pienaar ED, Bertholet N, et al. Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No: CD004148. [DOI: 10.1002/14651858.CD004148.pub4] - DOI - PMC - PubMed
Kazeem 2015
    1. Kazeem A, Car J, Pappas Y. Telephone consultations for the management of alcohol-related disorders. Cochrane Database of Systematic Reviews 2015, Issue 11. Art. No: CD009267. [DOI: 10.1002/14651858.CD009267.pub2] - DOI
Klatsky 2015
    1. Klatsky AL. Alcohol and cardiovascular diseases: where do we stand today? Journal of Internal Medicine 2015;278(3):238-50. [DOI: 10.1111/joim.12390] - DOI - PubMed
Kranzler 2018
    1. Kranzler HR, Soyka M. Diagnosis and pharmacotherapy of alcohol use disorder. A review. JAMA 2018;320(8):815-24. [DOI: 10.1001/jama.2018.11406] - DOI - PMC - PubMed
Larsson 2016
    1. Larsson SC, Wallin A, Wolk A, Markus HS. Differing association of alcohol consumption with different stroke types: a systematic review and meta-analysis. BioMed Central Medicine 2016;14(1):178. [DOI: 10.1186/s12916-016-0721-4] - DOI - PMC - PubMed
Lui 2008
    1. Lui S, Terplan M, Smith EJ. Psychosocial interventions for women enrolled in alcohol treatment during pregnancy. Cochrane Database of Systematic Reviews 2008, Issue 3. Art. No: CD006753. [DOI: 10.1002/14651858.CD006753.pub2] - DOI - PubMed
McQueen 2009
    1. McQueen J, Howe TE, Allan L, Mains D, Hardy V. Brief interventions for heavy alcohol users admitted to general hospital wards. Cochrane Database of Systematic Reviews 2011, Issue 8. Art. No: CD005191. [DOI: 10.1002/14651858.CD005191.pub3] - DOI - PMC - PubMed
Mills 2016
    1. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation 2016;134(6):441-50. [DOI: 10.1161/CIRCULATIONAHA.115.018912] - DOI - PMC - PubMed
Minozzi 2010
    1. Minozzi S, Amato L, Vecchi S, Davoli M. Anticonvulsants for alcohol withdrawal. Cochrane Database of Systematic Reviews 2010, Issue 3. Art. No: CD005064. [DOI: 10.1002/14651858.CD005064.pub3] - DOI - PMC - PubMed
Moyers 2009
    1. Moyers TB, Martin T, Houck JM, Christopher PJ, Tonigan JS. From in-session behaviors to drinking outcomes: a causal chain for motivational interviewing. Journal of Consulting and Clinical Psychology 2009;77(6):1113-24. [DOI: 10.1037/a0017189] - DOI - PMC - PubMed
NICE 2016
    1. National Clinical Guideline Centre. Hypertension in adults: diagnosis and management (CG127) (updated 2016). www.nice.org.uk/guidance/CG127 (accessed prior to 16 September 2020).
Pani 2010a
    1. Pani PP, Trogu E, Pacini M, Maremmani I. Anticonvulsants for alcohol dependence. Cochrane Database of Systematic Reviews 2010, Issue 6. Art. No: CD008544. [DOI: 10.1002/14651858.CD008544] - DOI - PMC - PubMed
Pani 2010b
    1. Pani PP, Trogu E, Amato L, Davoli M. Antidepressants for the treatment of depression in alcohol dependent individuals. Cochrane Database of Systematic Reviews 2010, Issue 7. Art. No: CD008581. [DOI: 10.1002/14651858.CD008581] - DOI
Puddey 2006
    1. Puddey IB, Beilin LJ. Alcohol is bad for blood pressure. Clinical and Experimental Pharmacology and Physiology 2006;33(9):847-52. [DOI: 10.1111/j.1440-1681.2006.04452.x] - DOI - PubMed
Rehm 2017
    1. Rehm J, Anderson P, Arbesu-Prieto JA, Armstrong I, Aubin HJ, Bachmann M, et al. Towards new recommendations to reduce the burden of alcohol-induced hypertension in the European Union. BMC Medicine 2017;15(173):1-10. [DOI: 10.1186/s12916-017-0934-1] - DOI - PMC - PubMed
RevMan 2014 [Computer program]
    1. Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Ricci 2018
    1. Ricci C, Wood A, Muller D, Gunter MJ, Agudo A, Boeing H, et al. Alcohol intake in relation to non-fatal and fatal coronary heart disease and stroke: EPIC-CVD case-cohort study. BMJ 2018;361:k934. [DOI: 10.1136/bmj.k934] - DOI - PMC - PubMed
Roerecke 2017
    1. Roerecke M, Kaczorowski J, Sheldon WT, Gerrit G, Omer SMH, Rehm J. The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis. Lancet Public Health 2017;2(2):e108-20. [DOI: 10.1016/S2468-2667(17)30003-8] - DOI - PMC - PubMed
Rösner 2010
    1. Rösner S, Hackl-Herrwerth A, Leucht S, Lehert P, Vecchi S, Soyka M. Acamprosate for alcohol dependence. Cochrane Database of Systematic Reviews 2010, Issue 9. Art. No: CD004332. [DOI: 10.1002/14651858.CD004332.pub2] - DOI - PMC - PubMed
Schünemann 2013
    1. Schünemann H, Brożek J, Guyatt G, Oxman A (editors). Introduction to GRADE Handbook. In: Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html.
Sesso 2008
    1. Sesso HD, Cook NR, Buring JE, Manson JE, Gaziano JM. Alcohol consumption and the risk of hypertension in women and men. Hypertension 2008;51(4):1080-7. [DOI: 10.1161/HYPERTENSIONAHA.107.104968] - DOI - PubMed
Smith 2009
    1. Smith EJ, Lui S, Terplan M. Pharmacologic interventions for pregnant women enrolled in alcohol treatment. Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No: CD007361. [DOI: 10.1002/14651858.CD007361.pub2] - DOI - PMC - PubMed
Stade 2009
    1. Stade BC, Bailey C, Dzendoletas D, Sgro M, Dowswell T, Bennett D. Psychological and/or educational interventions for reducing alcohol consumption in pregnant women and women planning pregnancy. Cochrane Database of Systematic Reviews 2009, Issue 2. Art. No: CD004228. [DOI: 10.1002/14651858.CD004228.pub2] - DOI - PMC - PubMed
Tasnim 2020
    1. Tasnim S, Tang C, Musini VM, Wright JM. Effect of alcohol on blood pressure. Cochrane Database of Systematic Reviews 2020, Issue 7. Art. No: CD012787. [DOI: 10.1002/14651858.CD012787.pub2] - DOI - PMC - PubMed
Taylor 2009
    1. Taylor B, Irving HM, Baliunas D, Roerecke M, Patra J, Mohapatra S, et al. Alcohol and hypertension: gender differences in dose-response relationships determined through systematic review and meta-analysis. Addiction 2009;104(12):1981-90. [DOI: 10.1111/j.1360-0443.2009.02694.x] - DOI - PubMed
Vaz de Lima 2010
    1. Vaz de Lima FB, Andriolo RB, Da Silveira DX. Dopaminergic antagonists for alcohol dependence. Cochrane Database of Systematic Reviews 2010, Issue 4. Art. No: CD008460. [DOI: 10.1002/14651858.CD008460] - DOI
Wellman 2016
    1. Wellman RJ, Vaughn JA, Sylvestre MP, O'Loughlin EK, Dugas EN, O'Loughlin JL. Relationships between current and past binge drinking and systolic blood pressure in young adults. Journal of Adolescent Health 2016;58(3):352-7. [DOI: 10.1016/j.jadohealth.2015.10.251] - DOI - PubMed
Xin 2001
    1. Xin X, He J, Frontini MG, Ogden LG, Motsamai OI, Whelton PK. Effects of alcohol reduction on blood pressure. A meta-analysis of randomized controlled trials. Hypertension 2001;38(5):1112-7. [DOI: 10.1161/hy1101.093424] - DOI - PubMed

References to other published versions of this review

Domínguez‐Cantero 2012
    1. Domínguez-Cantero M, Parent Mathias V, Rueda JR, Solà I, Garjón J, Saiz LC, et al. Alcohol intake reduction for controlling hypertension. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No: CD010022. [DOI: 10.1002/14651858.CD010022] - DOI - PMC - PubMed

Publication types

Associated data